Technology | April 08, 2008

Mediware Medication Management Software Features Safety Upgrades

The newest version of Mediware's medication management software suite reportedly offers enhanced data integration and functional improvements for tracking of medication orders, administrations and histories.

Version 3.0 is said to provide functional improvements to each application in order to streamline communication between clinicians throughout the hospital. It also includes integration points designed to ease collaboration with other systems within the client�s environment.

Specific product enhancements for the suite include updated safe medication practices information to meet JCAHO inpatient safety standards, improved medication profiles and clinical information, increased alerts and notifications and upgraded screens and displays.

Mediware's suite combines the company's MediREC, WORx, MediMA and MediCOE applications. MediREC includes automated medication reconciliation that electronically captures home medications and provides longitudinal medication records to support reconciliation throughout a patient's stay. WORx is a pharmacy management solution for inpatient and outpatient settings, including inventory management, online adjudication and Web-based access for remote users. MediMAR includes bedside administration and documentation tools designed to ensure the correct medications are delivered to the right patient at the right time. MediCOE�s electronic clinician ordering streamlines orders associated with poor handwriting or patient misidentification.

April 2003

Related Content

Effect of Daily Aspirin on First-Time Heart Attack and Stroke Risk Inconclusive
News | Pharmaceuticals | September 04, 2018
The jury is still out on whether people at moderate risk of a first heart attack or stroke should take daily aspirin to...
Blood Pressure and Cholesterol-lowering Drugs Continue to Improve Survival After a Decade
News | Pharmaceuticals | August 27, 2018
Blood pressure and cholesterol-lowering drugs continue to improve survival in patients with hypertension after more...
Pfizer Announces Positive Topline Results from Phase 3 ATTR-ACT Study
News | Pharmaceuticals | April 06, 2018
Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study met its primary endpoint...
Humanetics Presents Data on Drug to Protect Cardiac Cells From Space-Like Radiation

Photo from NASA

News | Pharmaceuticals | February 01, 2018
February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the Natio
Xarelto Significantly Reduces Major Cardioavascular Events in Stable CAD and PAD Patients
News | Pharmaceuticals | October 18, 2017
October 18, 2017 — Results from the pivotal Phase 3 COMPASS study found that the...
News | Pharmaceuticals | October 04, 2017
October 4, 2017 — MyoKardia Inc.
News | Pharmaceuticals | September 12, 2017
September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in pati
Merck Announces Results of REVEAL Outcomes Study of Anacetrapib
News | Pharmaceuticals | September 11, 2017
Merck and researchers in the Clinical Trial Service Unit at the University of Oxford announced the publication and...
Statins Associated With Improved Heart Structure and Function
News | Pharmaceuticals | May 26, 2017
Statins are associated with improved heart structure and function, according to research presented at EuroCMR 2017, May...
Feature | Pharmaceuticals | May 16, 2017
May 16, 2017 – Results of a groundbreaking clinical trial demonstrate the effectiveness of a novel, fast-acting nasal
Overlay Init